KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $40.1 billion.

  • Eli Lilly's Total Current Liabilities rose 6268.44% to $40.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 billion, marking a year-over-year increase of 6268.44%. This contributed to the annual value of $28.4 billion for FY2024, which is 396.95% up from last year.
  • Per Eli Lilly's latest filing, its Total Current Liabilities stood at $40.1 billion for Q3 2025, which was up 6268.44% from $39.0 billion recorded in Q2 2025.
  • Eli Lilly's Total Current Liabilities' 5-year high stood at $40.1 billion during Q3 2025, with a 5-year trough of $11.7 billion in Q1 2021.
  • For the 5-year period, Eli Lilly's Total Current Liabilities averaged around $21.6 billion, with its median value being $18.6 billion (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first crashed by 710.54% in 2021, then skyrocketed by 6268.44% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Total Current Liabilities stood at $15.1 billion in 2021, then rose by 13.85% to $17.1 billion in 2022, then skyrocketed by 59.25% to $27.3 billion in 2023, then increased by 3.97% to $28.4 billion in 2024, then soared by 41.46% to $40.1 billion in 2025.
  • Its Total Current Liabilities stands at $40.1 billion for Q3 2025, versus $39.0 billion for Q2 2025 and $30.1 billion for Q1 2025.